首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical medicine insights-oncology

缩写:

ISSN:N/A

e-ISSN:1179-5549

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引526
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lu Zhao,Yongkun Fang,Jingqiu Zhang et al. Lu Zhao et al.
Background: Gut microbiota are associated with the pathological features and development of colorectal cancer (CRC); however, how gut microbiota changes in patients with CRC is unknown. This study investigated the role of...
Youran Dai,Tianyin Ruan,Wenhui Yang et al. Youran Dai et al.
Background: Triple negative breast cancer (TNBC) is a deadly subtype of breast cancer with limited treatment options. Currently, programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors have become the first...
İbrahim Acır,Hacı Ali Erdoğan,Ertuğrul Toka et al. İbrahim Acır et al.
Background: The aim of this study is to examine the hematological and biochemical variables in patients diagnosed with cancer-related stroke who have different types of cancer and to evaluate the effects of these variable...
Evangelia Vlachou,Burles Avner Johnson,Jean Hoffman-Censits Evangelia Vlachou
Locally advanced and metastatic urothelial cancer (la/mUC) is an aggressive disease with poor prognosis. Platinum-based chemotherapy has remained the first-line treatment for decades and until recently no other treatment options existed. To...
Duvern Ramiah,Daniel Mmereki Duvern Ramiah
The promise of novel technologies to increase access to radiotherapy in low- and middle-income countries (LMICs) is crucial, given that the cost of equipping new radiotherapy centres or upgrading existing machinery remains a major obstacle ...
Han Shan,Mengmeng Wang,Shuohan Huang et al. Han Shan et al.
Background: The bevacizumab biosimilar (Encoda), which was approved by the National Medical Products Administration (NMPA) in China in 2019, is a biosimilar of bevacizumab. Approval of bevacizumab biosimilar (Encoda) for ...
Haibin Chen,Liang Sun,Zhi Yang et al. Haibin Chen et al.
Background: Brain metastases are crucial in cancer progression, requiring focused efforts on the screening, early detection, and treatment. However, accurate forecasting the postoperative prognosis of patients with non-sm...
Guanglin Cui,Aping Yuan,Sveinung W Sørbye et al. Guanglin Cui et al.
Background: Inflammation is the most important deriving force for the development of colitis-associated colorectal cancer (CAC) through the Inflammation-Pretumor dysplasia-CAC sequence. T helper (Th) subsets Th9 and Th17 ...
Amr Mohamed,Mai Elhawi,Marcus Trybula et al. Amr Mohamed et al.
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of neoplasms with an increasing incidence in the last few decades. Despite therapeutic advances in the management of GEP-NENs, resistance to many of these ...
Jing Wei,Fangzheng Jiao,Xiaoya Wang et al. Jing Wei et al.
Background: Breast cancer (BRCA), the hormone related malignant tumor, is well-known for poor prognosis. ZNF208 mainly acts as a transcription factor in various tumors, and the single nucleotide polymorphisms (SNPs) of ZN...